Literature DB >> 15082754

Rapid up-regulation of endothelial nitric-oxide synthase in a mouse model of Escherichia coli lipopolysaccharide-induced bladder inflammation.

Walter S Kang1, Frank J Tamarkin, Marcia A Wheeler, Robert M Weiss.   

Abstract

Increases in the signaling molecule nitric oxide (NO) during inflammation may be linked not only to inducible nitric-oxide synthase (iNOS) but also to endothelial (e)NOS. Escherichia coli lipopolysaccharide (LPS) induces an inflammatory response in the bladder and rapidly increases phosphorylation of Akt/protein kinase B (Akt), a key enzyme regulating proliferation, apoptosis, and inflammation. Activated Akt phosphorylates human eNOS at serine 1177 and subsequently increases NOS activity. Because Akt and eNOS are both localized in the bladder urothelium, phosphorylation of eNOS by Akt provides an attractive mechanism for rapid increases in urinary NO production. Female mice were intraperitoneally injected with LPS (25 mg/kg) or pyrogen-free water (control). Four hours before LPS injection, some mice were injected with wortmannin, which inhibits Akt phosphorylation. Levels of urinary cyclic GMP, a downstream product of NO, increase 75% within 1 h after intraperitoneal injection of LPS, and this increase is blocked by wortmannin. Bladder eNOS and phosphorylated eNOS protein increase 94 and 151%, respectively, 1 h after LPS treatment, whereas iNOS was not detected. Wortmannin decreases eNOS phosphorylation by 60%. Furthermore, bladder Ca(2+)-dependent NOS activity (eNOS, neuronal NOS) is increased 79 +/- 20% 1 h after LPS treatment, whereas there is no increase in Ca(2+)-independent (iNOS) activity (n = 4). Increases in urinary cyclic GMP, NOS activity, and eNOS protein and phosphorylation 1 h after induction of inflammation with LPS, indicate that eNOS plays a role in the early response to bladder inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15082754     DOI: 10.1124/jpet.104.066506

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins.

Authors:  Travis J Wiles; Bijaya K Dhakal; Danelle S Eto; Matthew A Mulvey
Journal:  Mol Biol Cell       Date:  2008-01-30       Impact factor: 4.138

2.  A role for Akt in the rapid regulation of inflammatory and apoptotic pathways in mouse bladder.

Authors:  Frank J Tamarkin; Walter S Kang; Justin J Cohen; Marcia A Wheeler; Robert M Weiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-07-11       Impact factor: 3.000

3.  Polyamine-mediated resistance of uropathogenic Escherichia coli to nitrosative stress.

Authors:  Jean M Bower; Matthew A Mulvey
Journal:  J Bacteriol       Date:  2006-02       Impact factor: 3.490

4.  Evaluation of the effects of ozone therapy on Escherichia coli-induced cytitis in rat.

Authors:  C Tasdemir; S Tasdemir; N Vardi; B Ates; Y Onal; S Erdogan; A Yucel; E Aglamis; Y Yakupogullari; R Altıntas; A Karaman
Journal:  Ir J Med Sci       Date:  2013-03-01       Impact factor: 1.568

5.  Uropathogenic Escherichia coli-induced inflammation alters mouse urinary bladder contraction via an interleukin-6-activated inducible nitric oxide synthase-related pathway.

Authors:  Te I Weng; Hsiao Yi Wu; Pei Ying Lin; Shing Hwa Liu
Journal:  Infect Immun       Date:  2009-05-26       Impact factor: 3.441

6.  Endothelial nitric oxide synthase phosphorylation in treadmill-running mice: role of vascular signalling kinases.

Authors:  Quan-Jiang Zhang; Shawna L McMillin; Jason M Tanner; Milda Palionyte; E Dale Abel; J David Symons
Journal:  J Physiol       Date:  2009-06-08       Impact factor: 5.182

Review 7.  Waging war against uropathogenic Escherichia coli: winning back the urinary tract.

Authors:  Kelsey E Sivick; Harry L T Mobley
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

8.  Conditioning of uropathogenic Escherichia coli for enhanced colonization of host.

Authors:  Jean M Bower; Hannah B Gordon-Raagas; Matthew A Mulvey
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

9.  Lipopolysaccharide reduces urethral smooth muscle contractility via cyclooxygenase activation.

Authors:  Fabiano B Calmasini; Eduardo C Alexandre; Mariana G Oliveira; Fábio H Silva; António G Soares; Soraia K P Costa; Edson Antunes
Journal:  J Physiol Biochem       Date:  2021-05-21       Impact factor: 4.158

10.  Altered nitric oxide bioavailability contributes to diesel exhaust inhalation-induced cardiovascular dysfunction in man.

Authors:  Jeremy P Langrish; Jon Unosson; Jenny Bosson; Stefan Barath; Ala Muala; Scott Blackwell; Stefan Söderberg; Jamshid Pourazar; Ian L Megson; Andrew Treweeke; Thomas Sandström; David E Newby; Anders Blomberg; Nicholas L Mills
Journal:  J Am Heart Assoc       Date:  2013-02-19       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.